Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_assertion type Assertion NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_head.
- NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_provenance.
- NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_assertion evidence source_evidence_literature NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_provenance.
- NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_assertion SIO_000772 20204404 NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_provenance.
- NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_assertion wasDerivedFrom befree-20140225 NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_provenance.
- NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_assertion wasGeneratedBy ECO_0000203 NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_provenance.